Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) FCF Margin: 2009-2025

Historic FCF Margin for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to 43.98%.

  • UNITED THERAPEUTICS's FCF Margin rose 383.00% to 43.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 47.05%, marking a year-over-year increase of 1446.00%. This contributed to the annual value of 37.55% for FY2024, which is 543.00% up from last year.
  • As of Q3 2025, UNITED THERAPEUTICS's FCF Margin stood at 43.98%, which was up 171.20% from 16.22% recorded in Q2 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's FCF Margin peaked at 65.79% during Q1 2023, and registered a low of -3,221.52% during Q4 2024.
  • Moreover, its 3-year median value for FCF Margin was 40.15% (2024), whereas its average is -260.24%.
  • In the last 5 years, UNITED THERAPEUTICS's FCF Margin skyrocketed by 3,869bps in 2022 and then tumbled by 323,323bps in 2024.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's FCF Margin stood at 25.05% in 2021, then crashed by 700bps to 18.05% in 2022, then tumbled by 633bps to 11.71% in 2023, then plummeted by 323,323bps to -3,221.52% in 2024, then skyrocketed by 383bps to 43.98% in 2025.
  • Its last three reported values are 43.98% in Q3 2025, 16.22% for Q2 2025, and 48.63% during Q1 2025.